These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 892237)

  • 1. Immunoreactive glucagon levels in obese-hyperglycemic (ob/ob) mice.
    Dubuc PU; Mobley PW; Mahler RJ; Ensinck JW
    Diabetes; 1977 Sep; 26(9):841-6. PubMed ID: 892237
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon and insulin relationships in the obese hyperglycemic mouse (ob/ob).
    Mahler RJ; Dubuc PU; Mobley PW; Ensinck JW
    Horm Metab Res; 1976 Jan; 8(1):79-80. PubMed ID: 1248793
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of plasma immunoreactive glucagon in obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ; Buchanan KD
    J Endocrinol; 1982 Nov; 95(2):215-27. PubMed ID: 6757362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immunoreactive glucagon concentrations in aging obese-hyperglycaemic (ob/ob) mice [proceedings].
    Flatt PR; Bailey CJ; Buchanan KD
    Biochem Soc Trans; 1980 Feb; 8(1):57-8. PubMed ID: 6989671
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucagon antiserum: a tool to investigate the role of circulating glucagon in obese-hyperglycaemic (ob/ob) mice [proceedings].
    Flatt PR; Swanston-Flatt SK; Bailey CJ
    Biochem Soc Trans; 1979 Oct; 7(5):911-3. PubMed ID: 510739
    [No Abstract]   [Full Text] [Related]  

  • 6. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
    Stevenson RW; Hutson NJ; Krupp MN; Volkmann RA; Holland GF; Eggler JF; Clark DA; McPherson RK; Hall KL; Danbury BH
    Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose tolerance in aging obese (ob/ob) and lean mice.
    Dubuc PU; Ristimaki S; Cahn PJ; Willis PL
    Horm Metab Res; 1983 Mar; 15(3):120-3. PubMed ID: 6343213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma free tryptophan, brain serotonin, and an endocrine profile of the genetically obese hyperglycemic mouse at 4--5 months of age.
    Garthwaite TL; Kalkhoff RK; Guansing AR; Hagen TC; Menahan LA
    Endocrinology; 1979 Nov; 105(5):1178-82. PubMed ID: 226347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice.
    Fukudo S; Virnelli S; Kuhn CM; Cochrane C; Feinglos MN; Surwit RS
    Diabetes; 1989 Nov; 38(11):1433-8. PubMed ID: 2576006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity dysregulates fasting-induced changes in glucagon secretion.
    Stern JH; Smith GI; Chen S; Unger RH; Klein S; Scherer PE
    J Endocrinol; 2019 Nov; 243(2):149-160. PubMed ID: 31454790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycemic (ob/ob) mice.
    Flatt PR; Kwasowski P; Howland RJ; Bailey CJ
    J Nutr; 1991 Jul; 121(7):1123-8. PubMed ID: 2051232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethanol on basal and arginine-stimulated plasma levels of glucose, insulin and glucagon in fasted unanesthetized rabbits.
    Potter DE; Morris JW
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):180-6. PubMed ID: 7002081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse.
    Lavine RL; Voyles N; Perrino PV; Recant L
    Endocrinology; 1975 Sep; 97(3):615-20. PubMed ID: 170069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood glucose, plasma insulin and plasma glucagon in NZO mice.
    Upton JD; Sneyd JG; Livesey J
    Horm Metab Res; 1980 Apr; 12(4):173-4. PubMed ID: 6993323
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma glucose and insulin response to glucagon and arginine in Aston ob/ob mice: evidence for a selective defect in glucose-mediated insulin release.
    Flatt PR; Bailey CJ
    Horm Metab Res; 1982 Mar; 14(3):127-30. PubMed ID: 7040198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice.
    Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH
    Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.